This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lowrey, T. S. Articles by Kudsk, K. A. Search for Related Content PubMed PubMed Citation Articles by Lowrey, T. S. Articles by Kudsk, K. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Risk Pregnancy Nutritional Support Triglycerides Hazardous Substances DB PROPOFOL Social Bookmarking                         What's this?

Pharmacologic Influence on Nutrition Support Therapy: Use of Propofol in a Patient Receiving Combined Enteral and Parenteral Nutrition Support

The Regional Medical Center, Department of Food and Nutrition

Alexander W. Dunlap, DVM, MD

The University of Tennessee, Memphis, Department of Clinical Pharmacy

Rex O. Brown, PHARMD, BCNSP

The Regional Medical Center, Department of Food and Nutrition, The University of Tennessee, Memphis, Department of Clinical Pharmacy

Roland N. Dickerson, PHARMD, BCNSP

The Regional Medical Center, Department of Food and Nutrition, The University of Tennessee, Memphis, Department of Clinical Pharmacy

Kenneth A. Kudsk, MD

The Regional Medical Center, Department of Food and Nutrition, The University of Tennessee, Memphis, Department of Clinical Pharmacy

Propofol is a lipid-based sedative that provides 1.1 kcal/mL. Because propofol has rapid onset and quick recovery, it is becoming used widely in critical care units. A 15-year-old critically ill pregnant patient received specialized nutrition support concomitantly with propofol infusion for sedation. A serum triglyceride concentration obtained on day 6 of the propofol infusion was 1100 mg/dL with no previous history of hyperlipidemia. Caloric intakes from propofol averaged 1275 kcal/d (range 445 to 2354 kcal/d) over a 5-day period. Infusion of propofol or any other lipid-based drug must be monitored closely when given in conjunction with enteral or parenteral nutrition to avoid the pitfalls of overfeeding and hypertriglyceridemia. Enteral and parenteral formulas must be manipulated to provide optimal nutrient intakes while not overfeeding with fat when using increased amounts of lipid-based drugs.

Nutrition in Clinical Practice, Vol. 11, No. 4, 147-149 (1996)
DOI: 10.1177/0115426596011004147


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. J. Taylor, J. Bowles, and C. Jewkes Propofol Use Precludes Prescription of Estimated Nitrogen Requirements J Intensive Care Med, March 1, 2005; 20(2): 111 - 117. [Abstract] [PDF]

				B. A. Mizock Nutritional Support in Acute Lung Injury and Acute Respiratory Distress Syndrome Nutr Clin Pract, December 1, 2001; 16(6): 319 - 328. [Abstract] [PDF]